[Event Report] Second Forum: The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems (September 13, 2018)
date : 10/2/2018
Tags: Future of the Health Care System, Innovation and Sustainability
![[Event Report] Second Forum: The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems (September 13, 2018)](https://hgpi.org/en/wp-content/uploads/sites/2/Innovation-and-Sustainability_20180913-1.jpg)
HGPI convened the Second Forum “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems” on September 13, 2018.
Based on the issues raised at the preparatory meeting “Rebalancing Healthcare Systems: Innovation and Sustainability Series – Issues Identified from the Trial Introduction of Cost-Effectiveness Assessment” held on May 31, we identified three key themes (technical issues, issues for institutionalization, and public understanding) to be discussed in FY2018 and have been conducting a series of forums.
In this meeting, a roundtable discussion on HTA implementation was held with experts from industry, government, academia, and civil society. The discussions included policy functions required for the future implementation of Cost-Effectiveness Assessment, as well as its impact on the current healthcare and drug pricing systems.
The next forum is scheduled as follows:
- The Third Forum (November): Public Understanding
– Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment –
Organizer: HGPI
Participants: Policymakers, representatives from the government, academia and private sectors
Opening (Explanatory introduction)
- Ryoji Noritake (President, HGPI)
Roundtable Discussions “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems”
Roundtable Speakers (Titles omitted, in Japanese syllabary order)
- Shunya Ikeda (Professor, Graduate School of Medicine/Public Health, International University of Health and Welfare)
- Yoshie Onishi (Director, Japan Operations, Creativ-Ceutical K.K.)
- Kosuke Kato (Managing Director, Edwards Lifesciences Limited)
- Isao Kamae (Project Professor, Graduate School of Public Policy, the University of Tokyo).
- Keiji Kono (Senior Vice President, Global Health Policy, External Affairs, Chugai Pharmaceutical Co., Ltd.)
- Shigekazu Komoto (Planning Officer, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naokazu Saito (Chief, Policy Intelligence Division, Integrated Market Access Department, Janssen Pharmaceutical K.K.)
- Hiroyuki Sakamaki (Professor, School of Management, Tokyo University of Science)
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Tomoyuki Takura (Project Professor, Department of Healthcare Economics and Health Policy, Graduate School of Medicine and Faculty of Medicine, the University of Tokyo)
- Toshio Nagase (Director, Government Affairs, Gilead Science K.K.)
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
- Yoshiyuki Majima (President, Pancreatic Cancer Action Network Japan)
Moderator
- Joji Sugawara (Associate, HGPI)
Since 2016, HGPI has conducted a series of expert meetings entitled “Rebalancing Healthcare Systems: Innovation and Sustainability” to facilitate open discussions on HTA. Throughout these meetings, we have worked to identify the issues and to provide policy recommendations. For the past activities, please refer to the “Activity Report – Special Edition on Innovation and Sustainability” (attached below).
Top Research & Recommendations Posts
- [Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
- [Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (November 19, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
- [Policy Recommendations] HGPI Joint Input to the Zero Draft Political Declaration on NCDs and Mental Health (May 23, 2025)
Featured Posts
-
2025-07-04
[Registration Open] (Webinar) The 136th HGPI Seminar “Where We Are Now and Where We Are Going Regarding PPI in Mental Health Research: Learning from the TOGETHER Project in the Form of Co-Creation” (July 28, 2025)
-
2025-07-04
[Event Report] The HGPI Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-07-04
[HGPI Policy Column] (No. 62) From the Dementia Project “The Current State of Dementia Policy in the International Community in 2025”
-
2025-07-04
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
-
2025-07-08
[Registration Open] Planetary Health Academy (Starts August 2025)